A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence ...

Anyone who has had the flu at least once knows what to expect: high fever, muscle aches, chills, and a general feeling of ...

T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy effectiveness. A research team led by Wolfgang Kastenmüller and Georg ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

Nigel McCracken, chief operating officer, Virax Biolabs explains how the ViraxImmune PAIS assay uses T cell responses and cytokine levels to detect immune dysfunction and identify viral triggers of ...

Scientists found that dormant viral genes can be reactivated in kidney cancer, prompting an immune response, offering new potential for immunotherapy. Dana-Farber researchers have discovered that in ...

The virus spreads to new host cells as the body grapples with this overwhelming immune response. Understanding these different infection strategies is key for developing life-saving vaccines ...

Occasionally, we also see surprisingly low CD4-cell counts among patients who control viral ... explored immune activation as a possible mechanism for this seemingly paradoxical response to ...

University of New Mexico Health Sciences researchers hope to launch human clinical trials in their quest for a vaccine to ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses the expansion of its ViraxImmune platform into areas such as transplant monitoring, vaccine efficacy, latent virus reactivation, and ...

Virology researchers have found that a specific protein modification to the immune protein MDA5 is key to how our bodies detect and respond to viruses and viral replication. The publication explains ...

A nanoparticle-based vaccine candidate for H5N1 avian influenza achieved 100% protection in preclinical trials, offering hope ...